This bill amends the definition of medical cannabidiol in Iowa law by replacing the existing language in Section 124E.2, subsection 10. The new definition specifies that medical cannabidiol encompasses any species of the cannabis plant or any mixture or preparation thereof, including whole plant extracts and resins. It outlines the acceptable forms of medical cannabidiol, which include oral forms (such as tablets, capsules, liquids, tinctures, and sublingual forms), topical forms (including gels, ointments, creams, lotions, and transdermal patches), and inhaled forms (limited to nebulizable inhaled forms, vaporizable dried raw cannabis, and other vaporizable forms of cannabis).

The bill aims to clarify and expand the types of cannabis products that can be classified as medical cannabidiol, thereby enhancing the medical cannabidiol program in Iowa. The inclusion of specific forms of delivery for medical cannabidiol is intended to provide patients with a broader range of options for treatment.

Statutes affected:
Introduced: 124E.2